[{"ID":"35384_75-2021_NCT00865371","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease.\n\nINCLUSION CRITERIA: - Is the individual a healthy, normal adult man who volunteers to participate?\n\nNO, the patient does not meet this criterion as they have Parkinson's disease.\n\nEXCLUSION CRITERIA: - Does the individual have a history of seizure, cranial trauma, or other predisposition to seizure?\n\nYES, the patient has a history of Parkinson's disease, which is a predisposition to seizure.\n\nTherefore, the patient is ineligible for the clinical trial.","PROBA":0.988036824},{"ID":"28014_40-2022_NCT04053699","TOPIC_YEAR":2022,"RESPONSE":"# A: eligible","PROBA":0.9981813207},{"ID":"30398_65-2021_NCT00125437","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 25-year-old man with type 1 diabetes and cardiomyopathy.\n\nAccording to the inclusion criteria, the patient must have a left ventricular ejection fraction (LVEF) of less than 35%. The patient's LVEF is not specified in the patient note, so we cannot determine if the patient meets this criterion.\n\nHowever, the patient does have nonischemic cardiomyopathy, which is an inclusion criterion.\n\nThe patient also has preserved renal function, as their creatinine level is not specified in the patient note but is presumably within normal limits.\n\nThe patient does not have hyperkalemia (>5.0 mEg\/L), as this is an exclusion criterion.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9843887978},{"ID":"25078_53-2021_NCT01402115","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 34-year-old woman from Jordan who comes to clinic with some general and non-specific bones and joints pain.\n\nBased on the patient's age (34), she is within the inclusion criteria age range of 40-70 years.\n\nThe patient's BMI is 23, which is within the normal weight range and not excluded by the exclusion criteria.\n\nThe patient is not taking any medications that are excluded by the exclusion criteria (estrogens, corticosteroids, or bisphosphonates).\n\nThe patient's laboratory study is remarkable for Vit D: 14ng\/ml and otherwise healthy, which suggests that the patient does not have any significant illness affecting bone metabolism.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nC: eligible","PROBA":0.9920235045},{"ID":"5309_12-2021_NCT01621971","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 34-year-old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation.\n\nINCLUSION CRITERIA:\n\n* patients undergoing mitral valve surgery for chronic mitral regurgitation\n\nThe patient meets this criterion.\n\n* estimated pulmonary hypertension (systolic PAP > 50 mmHg estimated by the velocity of tricuspid valve regurgitation in preoperative transthoracic echocardiography)\n\nThe patient's echocardiogram shows a systolic pulmonary artery pressure of 55 mmHg, which meets this criterion.\n\nThe patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9950851821},{"ID":"18652_27-2022_NCT00005657","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 31-year-old woman with a diagnosis of Lyme disease.\n\nThe clinical trial is for Genetics of Hepatitis C Virus Infection.\n\nLyme disease and Hepatitis C Virus Infection are two completely different conditions.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9984312722},{"ID":"35639_75-2021_NCT03301272","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 55 years old, which is within the age range of 45-80 years old specified in the inclusion criteria. Therefore, the patient meets the age requirement.\n\n#2: Diagnosis\nThe patient has been diagnosed with Parkinson's disease, which meets the inclusion criteria of having Parkinson's disease.\n\n#3: Rest tremor\nThe patient has a rest tremor of at least 3 cm amplitude, which meets the inclusion criteria.\n\n#4: Medication history\nThe patient has a history of being refractory to at least 2 categories of medications typically used as anti-parkinsonian agents, including levodopa formulations, dopamine agonists, amantadine, and anticholinergics. This meets the inclusion criteria.\n\n#5: Ability to make changes to medications\nThe patient must be able to make no changes to their anti-parkinsonian medications for 150 days (study duration). The patient's treating physician must confirm in writing prior to participating that the patient is able to do so. This is not explicitly stated in the patient note, but it is implied that the patient is able to make no changes to their medications since they are being considered for the clinical trial.\n\n#6: Allergy\nThere is no mention of any allergies in the patient note.\n\n#7: Cognitive function\nThere is no mention of cognitive function in the patient note.\n\n#8: Muscle weakness\nThere is no mention of muscle weakness in the patient note.\n\n#9: Pregnancy\nThere is no mention of pregnancy in the patient note.\n\n#10: Infection\nThere is no mention of infection in the patient note.\n\nBased on the patient note, the patient meets all the inclusion criteria and none of the exclusion criteria, so the patient is eligible for the clinical trial.","PROBA":0.9945613088},{"ID":"35828_75-2021_NCT04821830","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with a recent diagnosis of Parkinson's disease, which meets the INCLUSION CRITERIA of the clinical trial.\n\nThe patient's disease is classified as mild to moderate (Hoehn-Yahr Stage I), which also meets the INCLUSION CRITERIA.\n\nThe patient is about to start treatment with a L-Dopa preparation (Sinemet), which is an essential component of the clinical trial.\n\nThe patient does not have any of the EXCLUSION CRITERIA, such as other neurological diseases, depression, or cognitive impairment.\n\nTherefore, the patient is eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9912723248},{"ID":"35538_75-2021_NCT02370134","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease, which meets the inclusion criteria of the clinical trial.\n\nThe patient has a history of hypertension and hypercholesterolemia, which are not exclusion criteria.\n\nThe patient does not have a history of cardiac arrhythmia, renal failure, hepatic failure, seizure, or implanted devices such as cardiac pacemaker, pulse generator of deep brain stimulation, or intrathecal baclofen pump, which are exclusion criteria.\n\nThe patient is not taking any medications that may potentiate or attenuate tremor, such as antihistamines, benzodiazepine, or illicit drugs, which are exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9904236479},{"ID":"35697_75-2021_NCT03808675","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9864407182},{"ID":"35511_75-2021_NCT02037451","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with a clinical diagnosis of Parkinson's disease.\n\nYes, the patient meets the INCLUSION CRITERIA for the clinical trial.\n\nClinical diagnosis of Parkinson disease: Eligible","PROBA":0.9779865582},{"ID":"14149_30-2021_NCT03097237","TOPIC_YEAR":2021,"RESPONSE":"The patient is a woman with a BMI of 31, which is within the inclusion criteria range of 27-35 kg\/m2.\n\nShe has a high TSH level (13 mU\/L) and low free T4 level (0.2 ng\/dl), which indicates hypothyroidism. This is within the inclusion criteria of serum TSH \u22644.00 mIU\/L.\n\nShe is not taking any medication for her thyroid condition, which is within the inclusion criteria of not using nicotine products or e-cigarettes.\n\nShe has a history of thyroid disorder, which is within the inclusion criteria of thyroid disorder.\n\nShe is not pregnant or lactating, and does not wish to become pregnant during the study, which is within the inclusion criteria of not being pregnant or lactating or wishing to become pregnant during the study.\n\nShe is not allergic to any of the study foods, which is within the inclusion criteria of no food allergies or intolerances.\n\nShe is able to understand written and spoken Swedish, which is within the inclusion criteria of understanding written and spoken Swedish.\n\nTherefore, the patient is eligible for the clinical trial.\n\nC: eligible","PROBA":0.9867098012},{"ID":"6765_15-2021_NCT01897623","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient male?\n\nYes, the patient is male.\n\n#2: Does the patient have coronary artery disease?\n\nYes, the patient has a history of coronary artery disease.\n\n#3: Is the patient willing to participate?\n\nNot specified, but the patient is being treated and undergoing tests, so it is likely that they are willing to participate.\n\n#4: Is the patient already diagnosed or treated for an abdominal aortic aneurysm?\n\nNo, the patient is not already diagnosed or treated for an abdominal aortic aneurysm.\n\nBased on the criteria, the patient is eligible for the clinical trial.","PROBA":0.9786262274},{"ID":"35774_75-2021_NCT04308135","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9586077332},{"ID":"23470_33-2022_NCT03059043","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 20-year-old man with myopia, which meets the inclusion criteria of the clinical trial.\n\nThe patient is cooperative with his medical appointments, which is not a criterion for the clinical trial but is a positive aspect of the patient's condition.\n\nThe patient is working as a driver, which is not a criterion for the clinical trial but is a relevant aspect of the patient's life.\n\nThe patient has no preexisting ocular diseases or conditions other than myopia, which meets the exclusion criteria of the clinical trial.\n\nThe patient has no evidence of connective tissue disease or other systemic diseases that may confound the results of the study, which meets the exclusion criteria of the clinical trial.\n\nThe patient's anterior chamber depth is normal, which meets the inclusion criteria of the clinical trial.\n\nThe patient's endothelial cell density is normal, which meets the inclusion criteria of the clinical trial.\n\nThe patient's pupil diameter is smaller than 7.0 mm under mesopic condition, which meets the inclusion criteria of the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9907915122},{"ID":"13938_30-2021_NCT00271427","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 33-year-old woman with Hashimoto's thyroiditis, which is a clinically approved autoimmune thyroiditis.\n\nShe is currently using Levothyroxine (LT4) to keep her TSH levels in the lower half of the normal range.\n\nTherefore, the patient meets the INCLUSION CRITERIA for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9759230486},{"ID":"5545_12-2021_NCT04527367","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 34-year-old woman with Marfan's syndrome and severe mitral valve prolapse with regurgitation. This meets the inclusion criteria of the clinical trial, which is looking for patients with valvular heart disease in moderate and severe stages.\n\nTherefore, the patient is \"eligible\" for the clinical trial.","PROBA":0.9733715165},{"ID":"27645_40-2022_NCT01526915","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 23-year-old female who has prolonged oral bleeding after a tooth extraction.\n\nThe patient meets the INCLUSION CRITERIA:\n\n* Patient major (male or female): Eligible\n* Documented indication at the initial visit at day 0 (JO) for a maximum extraction of 3 teeth: Eligible\n* Treatment with nitrogenous or non-nitrogenous BP by intravenous injection or oral administration: Eligible (the patient has no history of bisphosphonate treatment)\n* Patient having received the specific information letter regarding the study and having signed the clarified consent form: Not Applicable (the patient is not being asked to sign a consent form)\n\nThe patient does not meet the EXCLUSION CRITERIA:\n\n* Patient having a maxillary or mandibulary OCN at Day 0 (JO): Not Applicable (the patient does not have a maxillary or mandibulary OCN)\n* Positive HIV serology at Day 0 (for patients belonging to the PRF group): Not Applicable (the patient does not have HIV serology)\n* Previous history of maxillo-cervico-facial radiotherapy: Not Applicable (the patient has no previous history of maxillo-cervico-facial radiotherapy)\n* Patients with estimated survival expectancy shorter than one year: Not Applicable (the patient's estimated survival expectancy is not shorter than one year)\n* Lack of social security cover: Not Applicable (the patient has social security cover)\n* Inability of the patient to respect the study follow-up: Not Applicable (the patient is able to respect the study follow-up)\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9927216204},{"ID":"27964_40-2022_NCT03751800","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 23-year-old female with heavy menstrual bleeding.\n\nINCLUSION CRITERIA:\n\n* Women in childbearing age, \u226518 years old, not intending to become pregnant during the next year.\n\nELIGIBLE\n\n* Women diagnosed with heavy menstrual bleeding or idiopathic menorrhagia according to medical criteria and based on clinical judgment.\n\nELIGIBLE\n\n* Women for whom the clinician decides, in agreement with the patient, to prescribe any of the available chronic hormonal treatments with the therapeutic indication of HMB in Spain (Mirena, Qlaira or Progevera).\n\nELIGIBLE\n\n* Women capable of reading and writing.\n\nELIGIBLE\n\n* Women who signed the informed consent.\n\nELIGIBLE\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9956523077},{"ID":"33481_71-2021_NCT00909766","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9976096079},{"ID":"6892_15-2021_NCT02972671","TOPIC_YEAR":2021,"RESPONSE":"#1: Male or female patients \u226520 years\n\nPatient is 70 years old, which is greater than or equal to 20 years, so this criterion is met.\n\n#2: Patients who are eligible for percutaneous coronary intervention (PCI)\n\nThe patient has a history of CAD and recent abdominal mass, which suggests that they may be eligible for PCI. However, this criterion is not explicitly stated in the patient note, so we cannot confirm that the patient is eligible for PCI based on this information alone.\n\n#3: The vessel should have a reference vessel diameter ranging from 2.5 mm to 3.75 mm.\n\nThe patient note does not provide information about the vessel diameter, so we cannot confirm that the patient meets this criterion.\n\n#4: All lesions of the patient must comply with the angiographic inclusion criteria and no more than 4 stents per patient are to be implanted.\n\nThe patient note does not provide information about the number of stents to be implanted or the angiographic inclusion criteria, so we cannot confirm that the patient meets this criterion.\n\nBased on the information provided, the patient is not eligible for the clinical trial because we cannot confirm that they meet the criteria for PCI and the vessel diameter is not specified.","PROBA":0.9906141165},{"ID":"6630_15-2021_NCT00630513","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.8770424016},{"ID":"27599_40-2022_NCT01190150","TOPIC_YEAR":2022,"RESPONSE":"#1: Is the patient generally healthy?\nYes, the patient is generally healthy.\n\n#2: Does the patient have a history of at least 1 year of cyclic heavy menstrual bleeding?\nYes, the patient has a history of heavy menstrual bleeding.\n\n#3: Does the patient meet the criteria for HMB based on laboratory and physical findings?\nYes, the patient meets the criteria for HMB based on laboratory and physical findings.\n\n#4: Is the patient sexually inactive or using an acceptable birth control method?\nYes, the patient is sexually inactive.\n\n#5: Does the patient have any exclusion criteria?\nNo, the patient does not have any exclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9977750143},{"ID":"14016_30-2021_NCT01420419","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 33-year-old woman who is breastfeeding and experiencing nipple pain.\n\nINCLUSION CRITERIA:\n\n* Maternal complaint of nipple pain with any sign of nipple trauma to one or both nipples\n\nELIGIBLE\n\nThe patient meets the inclusion criteria for the clinical trial.\n\nEXCLUSION CRITERIA:\n\n* Infant not expected to be discharged home with mother\n* Infant with congenital abnormalities that would impair breastfeeding\n* Maternal allergy to lanolin\n* Maternal health conditions that may interfere with breastfeeding (physical or mental illness) as determined by hospital staff\n\nNONE OF THE ABOVE EXCLUSION CRITERIA APPLY TO THE PATIENT\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9934120658},{"ID":"35823_75-2021_NCT04796246","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease, which meets the inclusion criteria of the clinical trial.\n\nHe is classified as Hoehn-Yahr Stage I, which is within the range of I-III on the Hoehn & Yahr motor staging scale, which also meets the inclusion criteria.\n\nThe patient is over 18 years old and a resident of the city of Porto Alegre\/RS, which also meets the inclusion criteria.\n\nThe patient has signed an informed consent form, which is a requirement for participation in the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9926707827},{"ID":"27622_40-2022_NCT01384331","TOPIC_YEAR":2022,"RESPONSE":"#1: Age\nThe patient is 23 years old, which is within the age range of 18-45 years for the clinical trial. Therefore, the patient meets the age criterion.\n\n#2: Implanon user\nThe patient is not an Implanon user, as the clinical trial is specifically for Implanon users. Therefore, the patient does not meet this criterion.\n\n#3: Prolonged or frequent bleeding\nThe patient has prolonged oral bleeding after a tooth extraction, which meets the criterion of prolonged bleeding. However, the clinical trial is focused on vaginal bleeding, and the patient's bleeding is related to a tooth extraction rather than menstrual bleeding. Therefore, the patient does not meet this criterion.\n\nBased on the information provided, the patient is not eligible for the clinical trial.","PROBA":0.979868541},{"ID":"5561_12-2021_NCT04766216","TOPIC_YEAR":2021,"RESPONSE":"The patient is not eligible for the clinical trial because she does not meet the inclusion criteria of being treated with warfarin therapy. The patient is being treated for Marfan's syndrome and mitral valve prolapse, and there is no mention of warfarin therapy in the patient's note. Therefore, the patient is not eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9867760373},{"ID":"30724_65-2021_NCT02230631","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 25-year-old man with type 1 diabetes confirmed with molecular analysis 7 years ago.\n\nYes, the patient meets the inclusion criteria of the clinical trial, which is T1DM (Type 1 Diabetes Mellitus) or T2DM (Type 2 Diabetes Mellitus) treated with insulin for more than 12 months.\n\nThe patient is also at least 18 years of age at the time of the survey, so they meet this criterion as well.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9885184337},{"ID":"5452_12-2021_NCT03390634","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.8572644396},{"ID":"35820_75-2021_NCT04781842","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease, which meets the inclusion criteria of the clinical trial.\n\nThe patient does not have any signs of inability to walk without physical assistance, which does not meet the exclusion criteria of the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nC: eligible","PROBA":0.9814034873},{"ID":"14087_30-2021_NCT02319538","TOPIC_YEAR":2021,"RESPONSE":"$}}%A: eligible","PROBA":0.8372718266},{"ID":"6958_15-2021_NCT03527706","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9098796993},{"ID":"35733_75-2021_NCT04054960","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease.\n\nYes, the patient meets the INCLUSION CRITERIA: - Patients diagnosed with Idiopathic Parkinson's disease (IPD).\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9975357871},{"ID":"17358_36-2021_NCT04136093","TOPIC_YEAR":2021,"RESPONSE":"#1: Is the patient a postmenopausal woman?\n\nB: eligible","PROBA":0.9373289839},{"ID":"16918_36-2021_NCT00489333","TOPIC_YEAR":2021,"RESPONSE":"The patient is obese, with a BMI of 41.54, which meets the inclusion criterion of BMI \u226530 kg\/m2.\n\nThe patient has high levels of triglycerides (150 mg\/dl), which meets the inclusion criterion of Triglycerides >150 mg\/dl.\n\nThe patient has high levels of LDL cholesterol (180 mg\/dl), which meets the inclusion criterion of LDL Cholesterol of >160 mg\/dl.\n\nThe patient has high levels of fasting blood glucose (140 mg\/dl), which meets the inclusion criterion of Fasting blood glucose >100 mg\/dl.\n\nThe patient has high blood pressure (130\/80 mm Hg), which meets the inclusion criterion of Blood pressure >130\/85 mm Hg.\n\nThe patient does not have any exclusion criteria, such as being morbidly obese (BMI >40 kg\/m2), taking any cholesterol-lowering medications, or having any systemic diseases.\n\nTherefore, the patient is eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9959679126},{"ID":"24954_53-2021_NCT00377312","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 34-year-old woman from Jordan who comes to clinic with some general and non-specific bones and joints pain.\n\nINCLUSION CRITERIA:\n\n* Healthy Caucasian, Hispanic or Asian subjects\n\nThe patient is Asian, so she meets this criterion.\n\n* Males and Females\n\nThe patient is a female, so she meets this criterion.\n\n* Non-smoker\n\nThe patient's smoking status is not specified, so she does not meet this criterion.\n\n* Ages 24 - 35 years old\n\nThe patient is 34 years old, so she meets this criterion.\n\n* Subjects will be recruited either from the employee pool of the University of Pittsburgh or the University of Pittsburgh Medical Center (UPMC), or the general population living in the vicinity.\n\nThe patient is not an employee of the University of Pittsburgh or UPMC, so she does not meet this criterion.\n\n* Participation in this study by an employee or a potential employee at the University of Pittsburgh or UPMC has no effect on their employment or potential employment.\n\nThe patient is not an employee or potential employee of the University of Pittsburgh or UPMC, so she meets this criterion.\n\n* Subjects in the study will be required to discontinue all vitamins and health food supplements two weeks prior to the study.\n\nThe patient's vitamin D level is normal, so she does not meet this criterion.\n\nBased on the provided information and the criteria for the clinical trial, the patient is not eligible for the clinical trial.","PROBA":0.9952612837},{"ID":"5483_12-2021_NCT03768115","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have dry eye symptoms that cannot be managed with currently available dry eye medication?\n\nYes, the patient has dry eye symptoms that cannot be managed with currently available dry eye medication.\n\n#2: Does the patient have a TBUT of \u226410s?\n\nNo, the patient does not have a TBUT of \u226410s.\n\n#3: Is there presence of corneal fluorescein staining?\n\nNo, there is no presence of corneal fluorescein staining.\n\n#4: Is the patient's visual acuity affected by poor tear film quality?\n\nNo, the patient's visual acuity is not affected by poor tear film quality.\n\n#5: Is there no contraindication for blood extraction\/plasmapheresis?\n\nYes, there is no contraindication for blood extraction\/plasmapheresis.\n\n#6: Is the patient between 21 to 99 years old?\n\nYes, the patient is between 21 to 99 years old.\n\n#7: Are there any skin lesions at the site of venepuncture in the antecubital area?\n\nNo, there are no skin lesions at the site of venepuncture in the antecubital area.\n\nBased on the criteria, the patient is not eligible for the clinical trial.","PROBA":0.9971195579},{"ID":"35513_75-2021_NCT02086825","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease.\n\nThe clinical trial is for patients with cirrhosis of the liver and acute renal failure.\n\nThe patient does not have cirrhosis of the liver or acute renal failure.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9978695387},{"ID":"23291_33-2022_NCT01699607","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 20-year-old man, which meets the inclusion criterion of being between 18 and 55 years old.\n\nThe patient has no current uncontrolled medical condition, such as neurological, cardiovascular, endocrine, renal, or liver pathology, which meets the inclusion criterion of having no history of a neurological or psychiatric disorder in the past 2 years.\n\nThe patient does not have any history of seizures, head injury, brain tumor, heart, liver, or kidney disease, which meets the exclusion criterion of having no history of serious medical or neurological illness.\n\nThe patient does not have any acute or unstable medical or neurological illness, which meets the exclusion criterion of having no acute or unstable medical or neurological illness.\n\nThe patient does not have any suicidal ideation or behavior, which meets the exclusion criterion of having no suicidal ideation or behavior.\n\nThe patient does not have any history of psychosis, which meets the exclusion criterion of having no history of psychosis.\n\nThe patient does not have any regular use of any psychotropic drugs, including anxiolytics and antidepressants, which meets the exclusion criterion of having no regular use of any psychotropic drugs.\n\nThe patient does not have any eating disorder, which meets the exclusion criterion of having no eating disorder.\n\nThe patient does not have any diabetes, which meets the exclusion criterion of having no diabetes.\n\nThe patient does not have any pacemaker or other ferromagnetic material in their body, which meets the exclusion criterion of having no pacemaker or other ferromagnetic material in their body.\n\nThe patient does not have any history of smoking, which meets the exclusion criterion of having no history of smoking.\n\nTherefore, the patient is eligible for the clinical trial. C: eligible.","PROBA":0.994212279},{"ID":"7102_15-2021_NCT04852406","TOPIC_YEAR":2021,"RESPONSE":"The patient is 70 years old and has a history of CAD, which meets the inclusion criterion of being over the age of 65.\n\nThe patient has a history of coronary artery disease with angioplasty within the past year, which meets the inclusion criterion of having a history of coronary heart disease.\n\nThe patient has a history of atrial fibrillation, which meets the inclusion criterion of having non-valvular atrial fibrillation.\n\nThe patient has a history of venous thromboembolism within the past year, which meets the inclusion criterion of having a history of venous thromboembolism.\n\nThe patient is scheduled to undergo intra-abdominal surgery, which meets the inclusion criterion of being scheduled to undergo surgery.\n\nThe patient has signed a written informed consent, which meets the inclusion criterion of having signed a written informed consent.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.","PROBA":0.9878681375},{"ID":"35755_75-2021_NCT04207268","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.8886707425},{"ID":"17263_36-2021_NCT03308487","TOPIC_YEAR":2021,"RESPONSE":"The patient is a woman who is not pregnant.\n\nThe clinical trial is about vitamin D supplementation during pregnancy.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nC: irrelevant","PROBA":0.9846871501},{"ID":"35416_75-2021_NCT01161966","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man who was recently diagnosed with Parkinson's disease.\n\nINCLUSION CRITERIA:\n\n* Is the individual a healthy, normal adult man or non-child bearing potential woman who volunteers to participate? - No, the patient has Parkinson's disease.\n\nEXCLUSION CRITERIA:\n\n* Does the individual have a history of allergy or hypersensitivity to zonisamide or sulfonamides? - No, there is no mention of allergies or hypersensitivities.\n* Does s\/he have clinically significant laboratory abnormalities that would interfere with the conduct or interpretation of the study or jeopardize his\/her safety? - No, there is no mention of laboratory abnormalities.\n* Does s\/he have significant history or clinical evidence of auto-immune, cardiovascular, gastrointestinal, hematological, hematopoietic, hepatic, neurological, ongoing infection, pancreatic, or renal diseases that would interfere with the conduct or interpretation of the study or jeopardize his\/her safety? - Yes, the patient has Parkinson's disease.\n* Does s\/he have serious psychological illness? - No, there is no mention of psychological illness.\n* Does s\/he have significant history (within the past year) or clinical evidence of alcohol or drug abuse? - No, there is no mention of alcohol or drug abuse.\n* Does s\/he have a positive urine drug screen, or a positive HIV-1, or hepatitis B or C screen, or a positive pregnancy test? - No, there is no mention of any positive screens.\n* Has s\/he consumed grapefruit or grapefruit juice during the 7-day period preceding study initiation? - No, there is no mention of grapefruit or grapefruit juice.\n* Is s\/he unable to refrain from the use of alcohol or xanthine-containing foods or beverages during periods beginning 48 hours prior to study drug administration and ending when the last blood sample has been taken? - No, there is no mention of alcohol or xanthine-containing foods or beverages.\n* Has s\/he used any prescription drug during the 14-day period prior to study initiation, or any OTC drug during the 72-hour period preceding study initiation? - Yes, the patient is taking Levodopa and Trihexyphenidyl.\n* Is s\/he unable to refrain from the use of all concomitant medications during the study? - Yes, the patient is unable to refrain from using Levodopa and Trihexyphenidyl.\n* Has s\/he donated or lost blood, or participated in a clinical study which involved the withdrawal of a large volume of blood (480 mL or more), during the six week period preceding study initiation? - No, there is no mention of donating or losing blood.\n* Has s\/he donated plasma during the two week period preceding study initiation? - No, there is no mention of donating plasma.\n* Has s\/he received an investigational drug during the 30 day Period preceding study initiation? - No, there is no mention of investigational drugs.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9963476778},{"ID":"14273_30-2021_NCT04482907","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 33-year-old woman with Hashimoto's thyroiditis, which is a type of autoimmune thyroid disease.\n\nThe clinical trial is titled \"Effect of Dill in Thyroiditis and Nodular Goiter Patients\" and is specifically looking at the effects of dill on patients with thyroiditis and nodular goiter.\n\nThe patient meets the inclusion criteria for the clinical trial as she has been diagnosed with Hashimoto's thyroiditis and has been prescribed Levothyroxine.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9861124575},{"ID":"6772_15-2021_NCT01945125","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have normal renal function?\nNo, the patient has chronic kidney disease (SCr 2.1 in [**3-17**]).\n\n#2. Does the patient have abnormal renal function?\nYes.\n\n#3. Is the patient excluded from the clinical trial?\nYes, the patient is excluded from the clinical trial because of abnormal renal function.","PROBA":0.9845677912},{"ID":"11756_17-2022_NCT02627339","TOPIC_YEAR":2022,"RESPONSE":"The patient is 67 years old, which is above the minimum age requirement of 10 years.\n\nThe patient has eye problems (slowly worsening vision in both eyes), which is a direct contradiction to the exclusion criterion of \"No eye diseases\". Therefore, the patient is not eligible for the clinical trial.\n\nC: excluded","PROBA":0.9816975505},{"ID":"27553_40-2022_NCT00835211","TOPIC_YEAR":2022,"RESPONSE":"The patient is a 23-year-old female who has prolonged oral bleeding after a tooth extraction. This meets the inclusion criterion of \"medically healthy subjects with clinically normal laboratory profiles and ECGs.\"\n\nThe patient does not have any of the exclusion criteria, such as being pregnant or lactating, having a medical condition requiring regular treatment with prescription drugs, or having a history of significant cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or psychiatric disease.\n\nThe patient does not have any of the exclusion criteria related to birth control methods, as she is not sexually active and has not been using any birth control methods.\n\nTherefore, the patient is eligible for the clinical trial.\n\nC: eligible","PROBA":0.9844359558},{"ID":"35758_75-2021_NCT04222088","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease.\n\nParkinson's disease is not listed as an exclusion criterion.\n\nThe patient is not pregnant or breastfeeding, and there is no mention of any other underlying chronic or severe diseases.\n\nThe patient is not taking any regular medication that may interfere with the antimalarial pharmacokinetics.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9880558829},{"ID":"30870_65-2021_NCT03605979","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 25-year-old man with type 1 diabetes, which meets the inclusion criteria of being >18 years and having type 1 diabetes.\n\nThe patient has been treated with insulin pump for more than three months, which also meets the inclusion criteria.\n\nThe patient has hypoglycemia unawareness with a hypoglycemia perception threshold below 60 mg\/dL, which meets the inclusion criteria.\n\nThe patient has had at least one severe hypoglycemia event in the previous year, which also meets the inclusion criteria.\n\nTherefore, the patient is eligible for the clinical trial.\n\nA: eligible","PROBA":0.9927753324},{"ID":"35323_75-2021_NCT00282152","TOPIC_YEAR":2021,"RESPONSE":"The patient is a 55-year-old man with Parkinson's disease, which meets the INCLUSION CRITERIA of the clinical trial.\n\nThe patient has a clinical diagnosis of probable idiopathic PD, which is one of the INCLUSION CRITERIA.\n\nThe patient has demonstrated a response to dopaminergic therapy, which is another INCLUSION CRITERIA.\n\nThe patient is Hoehn-Yahr Stage I, which is within the range of H&Y stages included in the INCLUSION CRITERIA (H&Y stages II when OFF medication).\n\nThe patient has no contraindications to surgery, which is another INCLUSION CRITERIA.\n\nThe patient is between 50 and 75 years old, which is within the age range included in the INCLUSION CRITERIA.\n\nThe patient is available for follow-up for four years, which is another INCLUSION CRITERIA.\n\nThe patient has given informed consent, which is another INCLUSION CRITERIA.\n\nThe patient's MRI is within normal range for age, which is another INCLUSION CRITERIA.\n\nThe patient has been taking levodopa or dopamine agonist therapy for greater than six months but less than or equal to four years, which is another INCLUSION CRITERIA.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nC: eligible","PROBA":0.9935027634}]
